{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:21:46Z","timestamp":1790634106254,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"funder":[{"DOI":"10.13039\/100009941","name":"Ministry of Defence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.cbi.2016.04.038","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T15:53:40Z","timestamp":1462118020000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"PB","title":["The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties"],"prefix":"10.1016","volume":"259","author":[{"given":"Helen","family":"Rice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Chris","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.H.","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2016.04.038_bib1","series-title":"National Security Strategy and Strategic Defence and Security Review 2015","year":"2015"},{"key":"10.1016\/j.cbi.2016.04.038_bib2","unstructured":"Organisation for the Prohibition of Chemical Weapons (OPCW) Executive Council, Decision on Destruction of Syrian Chemical Weapons, Thirty-Third Meeting of the OPCW Executive Council, 27 September 2013 EC-M-33\/DEC.1 OPCW, 2013."},{"key":"10.1016\/j.cbi.2016.04.038_bib3","series-title":"United Nations Mission to Investigate Allegations of the Use of Chemical Weapons in the Syrian Arab Republic","author":"Sellstr\u00f6m","year":"2013"},{"key":"10.1016\/j.cbi.2016.04.038_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7326\/M13-2799","article-title":"Lessons learnt from the Syria Sarin attack: evaluation of a clinical syndrome through social media","volume":"160","author":"Rosman","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1013-1194","article-title":"Syrian gas attack reinforces need for better anti-sarin drugs","volume":"19","author":"Dolgin","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib6","series-title":"Chemical Warfare Agents: Toxicology and Treatment","article-title":"Toxicology of organophosphate nerve agents","author":"Marrs","year":"2007"},{"key":"10.1016\/j.cbi.2016.04.038_bib7","series-title":"Best Synthetic Methods","article-title":"General Overview: Toxicology and medical treatment of organophosphorus compounds","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2016.04.038_bib8","first-page":"225","article-title":"Central respiratory effects versus neuromuscular actions of nerve agents","volume":"7","author":"Rickett","year":"1986","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11064-007-9508-5","article-title":"Percutaneous exposure to VX: clinical signs, effects on brain acetylcholine levels and EEG","volume":"33","author":"Joosen","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2016.04.038_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cbi.2010.06.010","article-title":"Percutaneous exposure to the nerve agent VX: efficacy of combined atropine, obidoxime and diazepam treatment","volume":"188","author":"Joosen","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.04.038_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/15563650.2011.568944","article-title":"Post-exposure therapy with human plasma-derived butyrylcholinesterase following percutaneous VX challenge in guinea-pigs","volume":"49","author":"Mumford","year":"2011","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0041-008X(03)00216-3","article-title":"Toxicokinetics of the nerve agent (+\/\u2212)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration","volume":"191","author":"van der Schans","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1207\/S15327876MP1402_3","article-title":"Performance impacts of nerve agents and their pharmacological countermeasures","volume":"14","author":"McDonough","year":"2002","journal-title":"Mil. Psychol."},{"key":"10.1016\/j.cbi.2016.04.038_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1081\/CLT-120015840","article-title":"Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents","volume":"40","author":"Kassa","year":"2002","journal-title":"J.\u00a0Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.7205\/MILMED.169.11.856","article-title":"Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination","volume":"169","author":"Hamilton","year":"2004","journal-title":"Mil. Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2006.01.006","article-title":"A\u00a0novel approach for medical countermeasures to nerve agent poisoning in the guinea-pig","volume":"27","author":"Wetherell","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2006.07.028","article-title":"Development of next generation medical countermeasures to nerve agent poisoning","volume":"233","author":"Wetherell","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tox.2006.04.020","article-title":"The effect of atropine dosage on the efficacy of other pretreatment and treatment medical countermeasures for nerve agent intoxication","volume":"233","author":"Koplovitz","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tox.2006.07.008","article-title":"Development of antidotes: problems and strategies","volume":"233","author":"Szinicz","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tox.2006.09.013","article-title":"Swine models in the design of more effective medical countermeasures against organophosphorus poisoning","volume":"233","author":"Dorandeu","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tox.2006.08.034","article-title":"Medical countermeasures to WMDs: defence research for civilian and military use","volume":"233","author":"Hamilton","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.toxlet.2011.04.006","article-title":"Evolution of and perspectives on therapeutic approaches to nerve agent poisoning","volume":"206","author":"Masson","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2016.04.038_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cbi.2013.09.015","article-title":"Limitations and challenges in treatment of acute chemical warfare agent poisoning","volume":"206","author":"Thiermann","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.04.038_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuro.2014.04.011","article-title":"Choice of approaches in developing novel medical countermeasures for nerve agent therapy","volume":"44","author":"Myhrer","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1017\/S1049023X00001254","article-title":"The threat of mid-spectrum chemical warfare agents","volume":"18","author":"Aas","year":"2003","journal-title":"Prehospital Disaster Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00213-002-1324-7","article-title":"Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus)","volume":"166","author":"Muggleton","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cbi.2016.04.038_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2006.06.008","article-title":"The acute treatment of nerve agent exposure","volume":"249","author":"Cannard","year":"2006","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib28","series-title":"The Effect of Atropine Sulphate on Military Efficiency, PTP310; WO 189\/648","author":"Cullumbine","year":"1952"},{"key":"10.1016\/j.cbi.2016.04.038_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tox.2006.04.043","article-title":"Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig","volume":"225","author":"Taysse","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib30","series-title":"Chemical Warfare Agents: Toxicology and Treatment","article-title":"Oximes","author":"Eyer","year":"2007"},{"key":"10.1016\/j.cbi.2016.04.038_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.2042-7158.1983.tb04316.x","article-title":"The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the Guinea-Pig","volume":"35","author":"Inns","year":"1983","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.taap.2006.10.001","article-title":"Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in\u00a0vitro analysis","volume":"219","author":"Worek","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib33","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1476-5381.2009.00330.x","article-title":"Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteers","volume":"157","author":"Abbara","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib34","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1476-5381.2010.01007.x","article-title":"Pharmacokinetic analysis of pralidoxime after its intramuscular injection alone or in combination with atropine-avizafone in healthy volunteers","volume":"161","author":"Abbara","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/bdd.2510160506","article-title":"The acetylcholinesterase oxime reactivator HI-6 in man \u2013 pharmacokinetics and tolerability in combination with atropine","volume":"16","author":"Clement","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.cbi.2016.04.038_bib36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0022-3565(25)23158-5","article-title":"Comparison of central-nervous-system and peripheral pharmacodynamics to atropine pharmacokinetics","volume":"255","author":"Ellinwood","year":"1990","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2016.04.038_bib37","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/0272-0590(85)90118-6","article-title":"HI-6 in man \u2013 blood-levels, urinary-excretion, and tolerance after intramuscular administration of the oxime to healthy-volunteers","volume":"5","author":"Kusic","year":"1985","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tox.2011.04.006","article-title":"Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning","volume":"285","author":"Lundy","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pharmthera.2013.04.009","article-title":"The value of novel oximes for treatment of poisoning by organophosphorus compounds","volume":"139","author":"Worek","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2016.04.038_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.lfs.2009.09.005","article-title":"Pharmacokinetics and immunologic consequences of repeated administrations of purified heterologous and homologous butyrylcholinesterase in mice","volume":"85","author":"Sun","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cbi.2005.10.025","article-title":"Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys","volume":"157","author":"Lenz","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.04.038_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.cbi.2013.06.012","article-title":"Progress in the development of enzyme-based nerve agent bioscavengers","volume":"206","author":"Nachon","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.04.038_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchromb.2008.08.001","article-title":"Chromatographic resolution, characterisation and quantification of VX enantiomers in hemolyzed swine blood samples","volume":"873","author":"Reiter","year":"2008","journal-title":"J.\u00a0Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cbi.2012.08.018","article-title":"Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning","volume":"203","author":"Mumford","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.04.038_bib45","first-page":"20140891","article-title":"Toxicity and medical countermeasures studies on the organophosphorus nerve agents VM and VX","volume":"471","author":"Rice","year":"2015","journal-title":"Proc. R. Soc. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib46","series-title":"The Pharmacokinetics of Medical Countermeasures Against Nerve Agents","author":"Armstrong","year":"2014"},{"key":"10.1016\/j.cbi.2016.04.038_bib47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/TA.0000000000000580","article-title":"Improved survival in UK combat casualties from Iraq and Afghanistan: 2003\u20132012","volume":"78","author":"Penn-Barwell","year":"2015","journal-title":"J.\u00a0Trauma Acute Care Surg."},{"key":"10.1016\/j.cbi.2016.04.038_bib48","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/SLA.0b013e31827eefcf","article-title":"En-route care capability from point of injury impacts mortality after severe wartime injury","volume":"257","author":"Morrison","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.cbi.2016.04.038_bib49","first-page":"S4","article-title":"Died of wounds on the battlefield: causation and implications for improving combat casualty care","volume":"71","author":"Eastridge","year":"2011","journal-title":"J.\u00a0Trauma Inj. Infect. Crit. Care"},{"key":"10.1016\/j.cbi.2016.04.038_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)61202-1","article-title":"Management of acute organophosphorus pesticide poisoning","volume":"371","author":"Eddleston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2016.04.038_bib51","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1212\/01.WNL.0000124519.85516.50","article-title":"The birth of nerve agent warfare \u2013 lessons from Syed Abbas Foroutan","volume":"62","author":"Newmark","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2016.04.038_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0196-0644(96)70052-5","article-title":"Report on 640 victims of the Tokyo subway sarin attack","volume":"28","author":"Okumura","year":"1996","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib53","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin experiences in Japan: acute toxicity and long-term effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2169\/internalmedicine.36.466","article-title":"Eighteen cases exposed to Sarin in Matsumoto, Japan","volume":"36","author":"Suzuki","year":"1997","journal-title":"Intern. Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/2008-2231-20-81","article-title":"Advances in toxicology and medical treatment of chemical warfare nerve agents","volume":"20","author":"Moshiri","year":"2012","journal-title":"Daru J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib56","series-title":"Monograph on Atropine, Antidotes for Poisoning by Organophosphorus Pesticides","author":"Heath","year":"2002"},{"key":"10.1016\/j.cbi.2016.04.038_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxlet.2011.07.006","article-title":"Atropine maintenance dosage in patients with severe organophosphate pesticide poisoning","volume":"206","author":"Thiermann","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2016.04.038_bib58","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2174\/092986709788803088","article-title":"Chemical aspects of pharmacological prophylaxis against nerve agent poisoning","volume":"16","author":"Bajgar","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2016.04.038_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002040050670","article-title":"Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication","volume":"74","author":"Shih","year":"2000","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(99)00060-1","article-title":"Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs","volume":"38","author":"McDonough","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.cbi.2016.04.038_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/qjmed\/95.5.275","article-title":"Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials","volume":"95","author":"Eddleston","year":"2002","journal-title":"Qjm Int. J. Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib63","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/toxsci\/kft217","article-title":"Reactivation of plasma butyrylcholinesterase by pralidoxime chloride in patients poisoned by WHO class II toxicity organophosphorus insecticides","volume":"136","author":"Konickx","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000104","article-title":"Pralidoxime in acute organophosphorus insecticide poisoning-a randomised controlled trial","volume":"6","author":"Eddleston","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0310057X0803600305","article-title":"Adjuncts and alternatives to oxime therapy in organophosphate poisoning-is there evidence of benefit in human poisoning? A review","volume":"36","author":"Peter","year":"2008","journal-title":"Anaesth. Intensiv Care"},{"key":"10.1016\/j.cbi.2016.04.038_bib66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00139709-200625040-00009","article-title":"The role of oximes in the treatment of nerve agent poisoning in civilian casualties","volume":"25","author":"Marrs","year":"2006","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.cbi.2016.04.038_bib67","first-page":"1652","article-title":"Acute organophosphorus poisoning","volume":"10","author":"Eddleston","year":"2003","journal-title":"Clin. Evid."},{"key":"10.1016\/j.cbi.2016.04.038_bib68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2016.04.038_bib69","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/138920112802273191","article-title":"Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) dermal exposure","volume":"13","author":"Schwartz","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.cbi.2016.04.038_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/15569527.2010.515280","article-title":"Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, Part 1: Guinea pigs challenged with VX","volume":"30","author":"Braue","year":"2011","journal-title":"Cutan. Ocular Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/15563650.2012.720986","article-title":"In\u00a0vivo decontamination of the nerve agent VX using the domestic swine model","volume":"50","author":"Misik","year":"2012","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2010.09.012","article-title":"Determination of threshold adverse effect doses of percutaneous VX exposure in African green monkeys","volume":"279","author":"Genovese","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/15376510600972733","article-title":"The toxicity of soman in the African green monkey (Chlorocebus aethiops)","volume":"17","author":"Despain","year":"2007","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.cbi.2016.04.038_bib74","first-page":"104","article-title":"Nonhuman primates are relevant models for research in hematology, immunology and virology","volume":"16","author":"Herodin","year":"2005","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cbi.2016.04.038_bib75","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0091-3057(96)00292-4","article-title":"Efficacy of atropine\/pralidoxime\/diazepam or atropine\/HI-6\/prodiazepam in primates intoxicated by soman","volume":"56","author":"Lallement","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.cbi.2016.04.038_bib76","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.2042-7158.1979.tb13504.x","article-title":"The protection of primates against soman poisoning by pretreatment with pyridostigmine","volume":"31","author":"Dirnhuber","year":"1979","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2011.03.004","article-title":"In\u00a0vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species","volume":"206","author":"Herkert","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2016.04.038_bib78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxlet.2010.02.007","article-title":"Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon","volume":"194","author":"Herkert","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2016.04.038_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tox.2007.10.021","article-title":"Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase","volume":"244","author":"Worek","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib80","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.taap.2014.10.009","article-title":"A\u00a0comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides","volume":"281","author":"Wilhelm","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0161-813X(02)00082-7","article-title":"Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig","volume":"23","author":"Wetherell","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib82","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/15563650.2013.780208","article-title":"N-acetyl-L-cysteine protects against inhaled sulfur mustard poisoning in the large swine","volume":"51","author":"Jugg","year":"2013","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib83","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3109\/08958378.2010.527398","article-title":"Exposure-response effects of inhaled sulfur mustard in a large porcine model: a 6-h study","volume":"22","author":"Fairhall","year":"2010","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib84","first-page":"245","article-title":"Furosemide in the treatment of phosgene induced acute lung injury","volume":"156","author":"Grainge","year":"2010","journal-title":"J.\u00a0R. Army Med. Corps"},{"key":"10.1016\/j.cbi.2016.04.038_bib85","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/08958370903571831","article-title":"Delayed low-dose supplemental oxygen improves survival following phosgene-induced acute lung injury","volume":"22","author":"Grainge","year":"2010","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jramc-155-02-05","article-title":"Early treatment with nebulised salbutamol worsens physiological measures and does not improve survival following phosgene induced acute lung injury","volume":"155","author":"Grainge","year":"2009","journal-title":"J.\u00a0R. Army Med. Corps"},{"key":"10.1016\/j.cbi.2016.04.038_bib87","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/15376510701623383","article-title":"Preliminary studies of sulphur mustard-induced lung injury in the terminally anesthetized pig: exposure system and methodology","volume":"18","author":"Fairhall","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.cbi.2016.04.038_bib88","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.28.1_supplement.1143.5","article-title":"Pupillary light response in guinea pigs and swine exposed to organophosphate agents","volume":"28","author":"Clarkson","year":"2014","journal-title":"Faseb J."},{"key":"10.1016\/j.cbi.2016.04.038_bib89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1742-7843.2005.pto_97106.x","article-title":"Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig","volume":"97","author":"Chilcott","year":"2005","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib90","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.bcp.2011.09.019","article-title":"Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Gottingen minipigs exposed to sarin vapor","volume":"82","author":"Saxena","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib91","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.201406-1150CI","article-title":"Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care","volume":"190","author":"Hulse","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2016.04.038_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/jramc-2013-000207","article-title":"Translational toxicological research: investigating and preventing acute lung injury in organophosphorus insecticide poisoning","volume":"160","author":"Hulse","year":"2014","journal-title":"J.\u00a0R. Army Med. Corps"},{"key":"10.1016\/j.cbi.2016.04.038_bib93","article-title":"Minipig model of dimethoate organophosphorus pesticide poisoning","volume":"105","author":"Eddleston","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2016.04.038_bib94","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2174\/1573406411309050008","article-title":"Structure-activity relationship for the reactivators of acetylcholinesterase inhibited by nerve agent VX","volume":"9","author":"Kuca","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.cbi.2016.04.038_bib95","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/ijms12032077","article-title":"In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase","volume":"12","author":"Jun","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2016.04.038_bib96","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cbi.2010.03.010","article-title":"Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs","volume":"187","author":"Skovira","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2016.04.038_bib97","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.toxlet.2015.08.013","article-title":"Pharmacokinetic profile and quantitation of protection against soman poisoning by the antinicotinic compound MB327 in the guinea-pig","author":"Price","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2016.04.038_bib98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1039\/C2MD00258B","article-title":"1,1\u2032-(Propane-1,3-diyl)bis(4-tert-butylpyridinium) di(methanesulfonate) protects guinea pigs from soman poisoning when used as part of a combined therapy","volume":"3","author":"Timperley","year":"2012","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.cbi.2016.04.038_bib99","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuro.2015.07.003","article-title":"Beneficial effects of a ketamine\/atropine combination in soman-poisoned rats under a neutral thermal environment","volume":"50","author":"Barbier","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2016.04.038_bib100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2010.02.047","article-title":"Modulators of metabotropic glutamate receptors microinfused into perirhinal cortex: anticonvulsant effects in rats challenged with soman","volume":"636","author":"Myhrer","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2016.04.038_bib101","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.neuropharm.2008.02.008","article-title":"Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain","volume":"54","author":"Bankstahl","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2016.04.038_bib102","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuro.2012.03.006","article-title":"Neuropharmacological specificity of brain structures involved in soman-induced seizures","volume":"33","author":"Skovira","year":"2012","journal-title":"Neurotoxicology"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716301685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716301685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:43:42Z","timestamp":1757857422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279716301685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":102,"alternative-id":["S0009279716301685"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2016.04.038","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2016.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}